According to a survey by Fortune Securities, the market size was 4,5 billion USD in 2013 and will reach 11,7 billion USD in 2018, an annual growth rate of over 20 %. , Chinese enterprises are mainly concentrated in the middle and lower sequencing services, but there is a tendency towards extending upstream. The 4 major market segments are genetic diagnosis, prenatal screening and diagnosis, preimplantation genetic diagnosis and tumor diagnosis and treatment.
China Bio news release, November 30, 2015